| 81 |
|
Advances in Brief - Brain Enriched Hyaluronan Binding (BEHAB)/Brevican Increases Aggressiveness of CNS-1 Gliomas in Lewis Rats./
|
Nutt, Catherine L
|
Williams and Wilkins
|
2001
|
|
|
|
| 82 |
|
Advances in Brief - BRCA1 Promoter Region Hypermethylation in Ovarian Carcinoma: A Population-based Study./
|
Baldwin, Rae Lynn
|
Williams and Wilkins
|
2000
|
|
|
|
| 83 |
|
Advances in Brief - Breast Cancer Susceptibility Gene 1 (BRCA1) Is a Coactivator of the Androgen Receptor./
|
Park, John J
|
Williams and Wilkins
|
2001
|
|
|
|
| 84 |
|
Advances in Brief - CDKN2A Germ-line Mutations in Individuals with Multiple Cutaneous Melanomas./
|
Hashemi, Jamileh
|
Williams and Wilkins
|
2001
|
|
|
|
| 85 |
|
Advances in Brief - Celecoxib Inhibits N-Butyl-N-(4-hydroxybutyl)-nitrosamine-induced Urinary Bladder Cancers in Male B6D2F1 Mice and Female Fischer-344 Rats./
|
Grubbs, Clinton J
|
Williams and Wilkins
|
2000
|
|
|
|
| 86 |
|
Advances in Brief - Cell Growth Inhibition by the Multifunctional Multivalent Zinc-Finger Factor CTCF./
|
Rasko, John E J
|
Williams and Wilkins
|
2001
|
|
|
|
| 87 |
|
Advances in Brief - Cell Surface Tumor Endothelial Markers Are Conserved in Mice and Humans./
|
Carson-Walter, Eleanor B
|
Williams and Wilkins
|
2001
|
|
|
|
| 88 |
|
Advances in Brief - Characterization of the 13q14 Tumor Suppressor Locus in CLL: Identification of ALT1, an Alternative Splice Variant of the LEU2 Gene./
|
Bullrich, Florencia
|
Williams and Wilkins
|
2001
|
|
|
|
| 89 |
|
Advances in Brief - Chloroquinoxaline Sulfonamide (NSC 339004) Is a Topoisomerase IIa/b Poison./
|
Gao, Hanlin
|
Williams and Wilkins
|
2001
|
|
|
|
| 90 |
|
Advances in Brief - Chromosomal Instability in Unirradiated Cells Induced in Vivo by a Bystander Effect of Ionizing Radiation./
|
Watson, Gwyneth E
|
Williams and Wilkins
|
2000
|
|
|
|
| 91 |
|
Advances in Brief - Cloning and Characterization of a Human Polyamine Oxidase That Is Inducible by Polyamine Analogue Exposure./
|
Wang, Yanlin
|
Williams and Wilkins
|
2001
|
|
|
|
| 92 |
|
Advances in Brief - Comparative Analyses of Transgene Delivery and Expression in Tumors Inoculated with a Replication-conditional or -defective Viral Vector./
|
Ichikawa, Tomotsogu
|
Williams and Wilkins
|
2001
|
|
|
|
| 93 |
|
Advances in Brief - Comparative Analysis of Necrotic and Apoptotic Tumor Cells As a Source of Antigen(s) in Dendritic Cell-based Immunization./
|
Kotera, Yoshihito
|
Williams and Wilkins
|
2001
|
|
|
|
| 94 |
|
Advances in Brief - Complete Inhibition of Rhabdomyosarcoma Xenograft Growth and Neovascularization Requires Blockade of Both Tumor and Host Vascular Endothelial Growth Factor./
|
Gerber, Hans-Peter
|
Williams and Wilkins
|
2001
|
|
|
|
| 95 |
|
Advances in Brief - Complete Inhibition of Vascular Endothelial Growth Factor (VEGF) Activities with a Bifunctional Diabody Directed against Both VEGF Kinase Receptors, fins-like Tyrosine Kinase Receptor and Kinase Insert Domain-containing Receptor./
|
Lu, Dan
|
Williams and Wilkins
|
2001
|
|
|
|
| 96 |
|
Advances in Brief - Constitutive Expression of ErbB-2 in Gallbladder Epithelium Results in Development of Adenocarcinoma./
|
Kiguchi, Kaoru
|
Williams and Wilkins
|
2001
|
|
|
|
| 97 |
|
Advances in Brief - Cooperative Interactions of Laminin 5 g2 Chain, Matrix Metalloproteinase-2, and Membrane Type-1-Matrix/Metalloproteinase Are Required for Mimicry of Embryonic Vasculogenesis by Aggressive Melanoma./
|
Seftor, Richard E B
|
Williams and Wilkins
|
2001
|
|
|
|
| 98 |
|
Advances in Brief - Cure of Burkitt's Lymphoma in Severe Combined Immunodeficiency Mice by T Cells, Tetravalent CD3 x CD19 Tandem Diabody, and CD28 Costimulation/
|
Cochlovius, Bj�n
|
Williams and Wilkins
|
2000
|
|
|
|
| 99 |
|
Advances in Brief - CYCLIN DI as a Genetic Modifier in Hereditary Nonpolyposis Colorectal Cancer./
|
Bala, Shashi
|
Williams and Wilkins
|
2001
|
|
|
|
| 100 |
|
Advances in Brief - Cyclooxygenase-2 Is Up-Regulated in Proliferative Inflammatory Atrophy of the Prostate, but not in Prostate Carcinoma./
|
Zha, Shan
|
Williams and Wilkins
|
2001
|
|
|
|
기사
(405)
